Journal of Southeast University (Medical Science Edition), Volume. 44, Issue 3, 370(2025)
Screening and clinical validation of prognosis-related differentially expressed LncRNAs in colon cancer based on gene chip technology
[1] [1] CHEN S, CAO Z, PRETTNER K, et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050[J]. JAMA Oncol, 2023, 9(4): 465-472.
[2] [2] VOGEL J D, FELDER S I, BHAMA A R, et al. The American society of colon and rectal surgeons clinical practice guidelines for the management of colon cancer[J]. Dis Colon Rectum, 2022, 65(2): 148-177.
[4] [4] FANG D, OU X, SUN K, et al. m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability[J]. Cancer Sci, 2022, 113(12): 4135-4150.
[5] [5] WU J, XU S, LI W, et al. lncRNAs as hallmarks for individualized treatment of gastric cancer[J]. Anticancer Agents Med Chem, 2022, 22(8): 1440-1457.
[6] [6] MA W, HU J. The linear ANRIL transcript P14AS regulates the NF-B signaling to promote colon cancer progression[J]. Mol Med, 2023, 29(1): 162.
[7] [7] TANG X, LIN Y, HE J, et al. Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma[J]. World J Surg Oncol, 2022, 20(1): 74.
[8] [8] WANG H, WU Y, WANG Z, et al. The LncRNA FEZF1-AS1 promotes tumor proliferation in colon cancer by regulating the mitochondrial protein PCK2[J]. Oncol Res, 2022, 29(3): 201-215.
[10] [10] BAKER K J, BRINT E, HOUSTON A. Transcriptomic and functional analyses reveal a tumour-promoting role for the IL-36 receptor in colon cancer and crosstalk between IL-36 signalling and the IL-17/IL-23 axis[J]. Br J Cancer, 2023, 128(5): 735-747.
[11] [11] WANG X, CHEN D, GUO M, et al. Oxytocin alleviates colitis and colitis-associated colorectal tumorigenesisvianoncanonical fucosylation[J]. Research (Wash D C), 2024, 7: 407.
[12] [12] BAKSHI H A, QUINN G A, NASEF M M, et al. Crocin inhibits angiogenesis and metastasis in colon cancerviaTNF-/NF-B/VEGF pathways[J]. Cells, 2022, 11(9): 1502.
[13] [13] REN C, HAN X, LU C, et al. Ubiquitination of NF-B p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance[J]. Cell Death Differ, 2022, 29(2): 381-392.
[14] [14] LIN S C, LIAO Y C, CHEN P M, et al. Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblastsviaintegrin-mediated NF-B and TGF-2 signaling[J]. J Biomed Sci, 2022, 29(1): 109.
Get Citation
Copy Citation Text
ZHAI Minghui, YUAN Dianbao, GAO Lingjuan, CHENG Danlei. Screening and clinical validation of prognosis-related differentially expressed LncRNAs in colon cancer based on gene chip technology[J]. Journal of Southeast University (Medical Science Edition), 2025, 44(3): 370
Category:
Received: Feb. 21, 2025
Accepted: Aug. 26, 2025
Published Online: Aug. 26, 2025
The Author Email: